Is Regenersis PLC A Buy After Today’s 20% Drop?

Falling knife or bargain buy? Roland Head takes a look at today’s profit warning from Regenersis PLC (LON:RGS).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in tech support outsourcing firm Regenersis (LSE: RGS) fell by 18% during the first hour of trading this morning, after the firm announced the loss of a major customer contract.

The firm’s shares have been drifting lower for most of this year, and this morning’s fall to around 161p means that Regenersis shares are now worth 46% less than one year ago.

Is Regenersis a falling knife that’s best avoided, or does the firm offer good value at the current price?

What’s gone wrong?

Regenersis says that as part of a process of consolidation, one of its larger clients will shift its European business to another supplier next year.

This is a significant loss for the firm’s Depot Solutions business, which provides outsourced electronic repair and refurbishment facilities to major manufacturers and retailers.

In this morning’s profit warning, the firm says that while results for the year ending 30 June 2015 will be unaffected, profit growth in 2015/16 will now be “modest”.

How will this affect profits?

The latest consensus forecasts for Regenersis (published before today) show a 21% rise in earnings per share for 2016.

In my view, today’s update suggests that most of this expected growth will be wiped out by poor performance from the Depot Solutions, leaving forecast profits broadly in-line with 2014/15 results.

That’s not necessarily a disaster. Earnings per share for the year just ended are expected to be 17.5p, implying a P/E of just 9.4 after today’s fall. The firm is expected to pay a dividend of 5p per share, giving a yield of 3%.

The good news

Depot Solutions accounted for almost half of Regenersis profits during the first half of the year. The remaining 52% came from the firm’s Advanced Solutions division.

This appears to offer much more potential. Regenersis reported an adjusted operating margin of 20.0% for the Advanced Solutions division during the first half of last year, compared to just 5.2% for Depot Solutions.

Regenersis expects “strong growth” in the Advanced Solutions division this year, Profits should also be helped by growth from a recent acquisition, Blancco, which provides data erasure services for businesses.

This is apparently a profitable business. Blancco’s adjusted operating profit rose by 45% during its first full year as part of Regenersis, according to today’s update.

The big risk?

I’m beginning to think that Regenersis could be an interesting contrarian buy, but I do have some concerns.

Regenersis raised £100m in a placing in March 2014 to fund the acquisition of Blancco and repay debt. At the time, the firm said that it believes opportunities for growth remained strong.

In today’s update, Regenersis appeared to do something of a U-turn on this statement, saying that in 2016 the board will “focus on actions to maximize shareholder value”.

This suggests to me that the firm is not expecting much in the way of growth, so will try to keep shareholders happy by hiking the dividend or perhaps disposing of some non-core assets.

Buy or sell?

In my view, Regenersis looks reasonably priced following today’s fall. However, there is a risk that more profit warnings could follow today’s announcement.

I plan to do some further research before deciding whether the shares rate as a buy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »